Predictive toxicity

Fluofarma's innovative technology brings high throughput to in vivo predictive toxicity analysis.

Services for toxicity testing

Our predictive technology can be used to test toxicity at an early stage in a drug's development and enables pharmaceutical companies to obtain their compounds' ecotoxicity, cytotoxicity and genotoxicity profiles using a single method.

Cytotoxicity

Study of cell membrane integrity
Apoptosis
Cytolysis
Oxidative stress
Mitochondrial function
Cell proliferation… 

Genotoxicity

Quantification of DNA damages
Quantification of DNA repair
Micronuclei analysis 

Download Toxicity.pdf

Breaking news

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal Cell Research.

    Read more [+]

  • Publication

    Fluofarma cited in a Biocompare featured article “Flow Cytometry Gets a Makeover”

    Read more [+]

  • Press Release

    Roche adopts Fluofarma’s high-content screening platform.

    Read more [+]

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal "Analytical Chemistry".

    Read more [+]

  • ECCP 2010

    Fluofarma will be attending the European Cancer Cluster Partnering 2010 in Oslo, from September 15th to 17th.

    Read more [+]

  • BIO-Connexion Congress

    Fluofarma will be attending the Bio-Connexion Congress in Paris, from October 6th to 7th.

    Read more [+]

  • 22nd EORTC-NCI-AACR symposium

    Fluofarma will be exhibitor at the 22nd EORTC-NCI-AACR symposium in Berlin from November 16th to 19th.

    Read more [+]

Roche adopts Fluofarma’s platform
October 19, 2009 – Fluofarma announced today that it entered into a multi-year agreement with Roche.
Read More



ALL NEWS